Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia

Clinical trial NCT02078219 · COMPLETED

Trial details

NCT number: NCT02078219
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gout and Hyperuricemia

Start date: 2014-01-05
Primary completion: 2015-03-13
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.